I guess we can expect some big volumes and (hopefully) upward pressure when things open today, following NBIX's announcement at the bell yesterday. Can anyone elaborate on which of NBIX's programs are most enhanced by the NNL technology?
Reading all the messages about nbix. Please know what you have invested in. Products are still years away and this is a long term hold. Dont expect to make money on short term movements. The real story here is a) strong new technology b) several collaborations with big pharma that bring not only cash but validation of the technology, c) so much cash from collaborations that their expenses are covered each of the past two years and they actually showed a profit with no sales (unheard of in biotech) d) an extremely strong cash position of nearly $80mm that is there for them in invest ( the one critisicm i have is i wish they would do something with that cash).e) an extermely bright and capaable management team led by a CEO who was head of Business Devlp at Genentech and understandfs this industry as well as anyone. The risks of biotech are still there but they have covered them as well as any compoany I know. Until Phase III data come is, there will be no significant movement outside the market as is the case with all biotech. Buy for the long term!!! Movements between 7 and 10 will go on for a couple of years but if you want to 3x+ ytour money this is one of the places to place a bet
I think you did a great job covering all the major points concerning NBIX and your info. will be helpful for people who are not real familiar with NBIX or there specific studies. It would be nice to pique a little interest in this board. For what its worth, I've made some decent money buying this stock between $7 and $8, then turning around and selling between $10 and $11. It's my experience the money to be made on biotechs is made on news releases which causes upward momentum. For example, how many years will it be before ENMD will see $85/sh. again? Their one day move was based upon a news release. Another example which I have personal experience in is IMNR in 1991. They were a new Biotech with a famous scientist on their research team (Dr. Jonas Salk). Early in 1991 I purchased this stock for $4/sh. News was released that the FDA was going to expedite approval of IMNR's HIV therapeutic and the stock shot up to over $60/sh. in the 4th Q. of 1991. The FDA decided against expedited review and the stock has been dropping ever since. There are many more examples. Therefore by purchasing stock in companies similar to NBIX at $8/sh. which has much more potential to increase from $8 than to decline, you are giving yourself a better chance to find the next ENMD or IMNR while limiting your risk.
...Northwest Neurologic, Inc., a privately-held company. It is in Portland (hence "Northwest", eh?), and is associated with the Oregon Health Sciences University and Vollum Institute. The details are available at Neurocrine's website (http://www.neurocrine.com). Click "Investor Relations", then "Press Releases".
Not surprising that NBIX dropped today in wake of the news (if anyone saw it, that is), since the acquisition will involve the issuing of $4.2 million in additional shares.